Anti- Arrythmic Drugs Pt.1 Flashcards

1
Q

Cardiac condxn system

A
  1. SA node fires
  2. Excitation spreads through atrial myocardium
  3. AV node fires
  4. Excitation spreads through AV bundle
  5. Purkinje fibers distribute excitation through ventricular myocardium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

‘ACTION POTENTIAL IN FAST-RESPONSE FIBERS VENTRICULAR MYOCYTES, HIS-PURKINJE SYSTEM
Phase 0- 4

A

A) Phase 0: Rapid depolarization
-Inward current of Na+
B) Phase 1: Partial repolarization
- Na+ current is inactivated
- There may also be a transient voltage-sensitive outward current
C) Phase 2: Plateau
- Inward Ca2+ current
-Small outward potassium channel 
D) Phase 3: Repolarization
- Delayed outwardly rectifying K+ current
E) Phase 4: Return of membrane to resting potential

(Ca2+ in, K + out)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ACTION POTENTIAL IN SLOW-RESPONSE FIBERS SA NODE, AV NODE

A
  • Phase 0: Depolarization
    • Inward current: L-type Ca Channels and T-type Ca channels
  • Phase 3: Repolarization
    • Delayed rectifier K+ current
  • Phase 4: pacemaker current
    • Slope will determine pacemaker activity i.e. at the SA node
    • Inward Na+ current hyperpolarization-activated channel
    •Inward Ca2+ current • Outward K+ current
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

DISTURBANCES OF CARDIAC RHYTHM

Classified according to:

A

Site of origin e.g.
- Atrial - Ventricular

Rate
- Increased rate (tachycardia) e.g.
•Atrial fibrillation
• Ventricular fibrillation

  • Decreased rate (bradycardia) e.g.
    • Heart block
    • Asystolic arrest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ANTI-ARRHYTHMIC DRUGS
Class I-IV

A

 Class I: Na+ channel blockers
 Class II: Beta-blockers
 Class III: K+ channel blockers
 Class IV: Ca2+ channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

‘CLASS I: Na+ CHANNEL BLOCKERS ‘USE-DEPENDENT’
-Na+ channels move between 3 states

A

 Closed: Resting potential
-Activation (a) gate is closed and hinge (h) gate is open
 Open: Activated by electrical signal causing depolarization
- Both gates are open
C), Inactivated (refractory): at the peak of the AP the channels are inactivated by closing the (h) gate, gate (a) remains open

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

-CLASS I I: Na+ CHANNEL BLOCKERS ‘USE-DEPENDENT
, Inhibit /,,

A

-Inhibit action potential propagation in excitable
cells
 Reduce the maximum rate of depolarization at
phase 0 in non-nodal cells
- Use-dependent Na+ channel blockade

M Bind to activated and inactivated rather than closed

  • Hyperkalemia causes increased toxicity for all
    class I drugs channels
  • Block high frequency excitation of the myocardium
    without affecting beating of the heart at normal
    frequencies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CLASS IA: Na+ CHANNEL BLOCKERS
, Mechanism of Action (and Adverse Effects)

A
  • Preferentially block channels in the open or activated state
  • Prolong repolarization (K+ channel blockade): less than class III
  • Increase action potential duration (APD) and ERP
    • QT interval prolongation associated with torsades and syncope
  • Intermediate dissociation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CLASS IA: Na+ CHANNEL BLOCKERS
Examples

A
  1. Quinidine
  2. Procainamide
  3. Disopryamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Anti-cholinergic effects:

A

blurred vision, dry mouth, constipation, increased intraocular pressure, urinary retention, increase HR and AV conduction
- May need initial digitilization to slow AV conduction
- Useful in recurrent paroxysmal Afib triggered by vagal overactivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Quinidine
AE

A

Anticholinergic (moderate)
-> cinchonism (blurred vision, tinnitus, headache, psychosis) cramping and nausea, enhances digitalis toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Procainamide
AE

A

-anticholinergic (weak) , relatively short half- life

-> lupus like syndrome in 30% of pts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Disopryamide
AE

A

Αnticholinergic (strong)

  • negative inotropic effect
    Most commonly used
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Class 1A drugs clinical uses

A

Afib, flutter, supraventricular & ventricular tachyarrythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CLASS IB: Na+ CHANNEL BLOCKERS
Examples

A

lidocaine (IV), mexiletine (oral)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

lidocaine (IV), mexiletine (oral)
PK

A
  • Rapid dissociation
  • Bind selectively to inactivated channels in ventricular and Purkinje fiber cells
  • Block preferentially depolarized cells (e.g. ischemia/hypoxia)
  • Block premature beats
  • Decrease APD
17
Q

-lidocaine (IV), mexiletine (oral)
, Indications

A
  • Ventricular arrhythmias, particularly post-MI
  • Digoxin toxicity
18
Q

lidocaine (IV), mexiletine (oral)

Adverse effects

A

drowsiness, disorientation, convulsions, CV
depression, tremor

19
Q

“CLASS IC: Na+ CHANNEL BLOCKERS
Examples :

A

-flecainide, encainide

20
Q

‘CLASS IC: Na+ CHANNEL BLOCKERS
PK

A

-Associate and dissociate much more slowly than ‘ other classes
- Long-acting, given orally
- Blockade does not vary appreciably during the cardiac cycle
- Markedly inhibit conduction through the His-Purkinje system
- Suppress ventricular ectopic beats

-No effect on APD
- No effects on the autonomic nervous system

21
Q

Disadvantages of flecainide, encainide

A

unexpectedly increased risk of sudden death (in clinical trials)

  • Associated with VFib after MI
  • Prophylactically in VT also caused sudden death
  • No longer used in this setting
22
Q

Main use of flecainide + CI

A

is prophylaxis against paroxysmal atrial fibrillation

  • For patients without structural abnormalities
    • Contraindicated in structural and ischemic heart disease
  • Recurrent tachyarrhythmias associated with abnormal conducting pathways (e.g. Wolff-Parkinson-White-Syndrome)
23
Q

Flecainide
Clinical uses+ AE

A
  • SVT

AE: can induce life- threatening VT

24
Q

Propafenone Clinical uses + AE

A

SVT & VT
SE: β-blockers & Ca 2+ channel blocking activity can worsen heart failure

25
Q

Class IA anti-arrhythmics cause ______ refractory period.

A

An increase

26
Q

True or False
Class IA drugs cause K+ channel blockade, while Class IB drugs do not.

A

-true

27
Q

Which drug is contraindicated for the treatment of atrial fibrillation in a patient with dilated cardiomyopathy?

A

Flecainide (b/c of structural abnormalities )